A Snapshot of Five Contenders to Combat Infectious Diseases in the Post-Pandemic Landscape
Infectious disease is the focus of the biopharma track at INVEST Pitch Perfect May 20-21 in Chicago. Register today!
Pfizer Meningococcal Vaccine Nabs FDA Nod, Offering More Convenient Dosing
The FDA approved Pfizer’s Penbraya for vaccinating against five bacterial groups that can cause meningococcal disease. Pfizer already has vaccines covering those groups, but Penbraya addresses all of them in a single vaccine, making dosing easier for patients.
presented by
What Keeps Healthcare CIOs Up at Night: Balancing Technology Investments with Consumer Expectations
When it comes to managing inbound phone calls, underperformance has devastating cost implications.
Pfizer Shaves Revenue Projections, Starts Cost-Cutting Plan Amid Lower Covid-19 Product Demand
Pfizer lowered its revenue projections for 2023, a change it attributed to declining demand for its Covid-19 vaccine, Comirnaty, and antiviral drug, Paxlovid. Citing this revenue decline, Pfizer is implementing a companywide cost-cutting plan projected to save $3.5 billion.
Pfizer’s RSV Vaccine Wins FDA Approval on Heels of Regulatory Nod for GSK
Pfizer’s Abrysvo is now approved for preventing illness caused by respiratory syncytial virus, or RSV, in adults 60 and older. The regulatory decision comes weeks after GSK won approval for its RSV vaccine, Arexvy.
Medable rolls out new decentralized trial software for speedier vaccine development
Medable recently launched a software solution to shorten the launch times for decentralized vaccine trials. The company says the software can reduce trial deployment timelines from more than 12 weeks on average to as short as five weeks.
Epic deploys Covid-19 vaccine credentialing feature
Epic's Covid-19 vaccine credential, which shows up as a QR code within the MyChart patient portal, can be used to verify a person's immunization status. About 25 million people currently have access to the vaccine credential, and Epic plans to expand it to 100 million by 2022.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Analysis: Cost of care for unvaccinated Covid patients spikes to $5.7B
The cost of hospital care for unvaccinated Covid-19 patients has more than doubled, jumping from about $2 billion to $5.7 billion over the summer. And this figure may still be lower than the actual cost burden unvaccinated people represent to the healthcare system.
As Delta surges, CMIOs’ focus on plans to provide vaccine booster shots, fight false information
Chief medical information officers are in a unique position to help their organizations fight the Covid-19 pandemic — from setting up IT systems to support Covid testing, care and vaccination to helping fight fast-spreading misinformation.
Analysis: Care for the unvaccinated may be costing U.S. healthcare system $2.3B
The report, released by Kaiser Family Foundation and the Peterson Center on Healthcare, details the high cost of Covid care for the unvaccinated. In fact, the analysis indicates the figure could be even higher than $2.3 billion, as the authors did not take into account the cost of outpatient treatment for Covid-19.
Providers will likely face more lawsuits against vaccine mandates. But they are also more likely to win.
Providers' legal defense against lawsuits aiming to tear down vaccine mandates is wide-ranging, from making the argument that allowing an unvaccinated worker into their facilities could pose a direct threat to the worker to invoking a 1905 precedent set by the Supreme Court.
Using Data to Help Healthcare Practices Succeed
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
Poll: About half of healthcare workers feel burned out, anxious when going to work
Though a majority of healthcare workers believe that the pandemic is at least somewhat under control now, about half still feel anxious or burned out when going to work, a new survey shows. Pandemic-related stress has also given rise to physical issues among healthcare workers, including trouble sleeping and headaches.
J&J seeks emergency use for Covid-19 vaccine, FDA advisory panel is next
Johnson & Johnson’s Covid-19 vaccine offers storage and distribution advantages compared to mRNA vaccines, and is the only single-shot vaccine to reach late-stage testing. The next stop is a Feb. 26 FDA advisory panel meeting.
Companies vie for a role in federal vaccine plans — and for their workers to get vaccinated
Amazon, Walmart, Starbucks and other retailers are offering to play a bigger role in helping distribute Covid-19 vaccines. In most states, essential workers are still waiting for their first dose.
YouTube teams up with providers, healthcare groups to combat health misinformation
The video-sharing giant is partnering with providers and groups, like Mayo Clinic and the American Public Health Association, to create evidence-based health content. YouTube has also added CVS Health's former chief community health officer to lead those efforts.
Some much-needed help: HHS doles out $22B for testing, vaccines
States will get some much needed support to roll out a coronavirus vaccine. Last week, the Department of Health and Human Services shared it would roll out $22 billion in funding to support state testing and vaccination efforts.